News ArticleKrishna Institute of Medical Sciences Reappoints CEO and Chairman, Approves Subsidiary Merger and Operations Agreement
Board approves five-year reappointments of Dr. Abhinay Bollineni and Dr. Bhaskara Rao Bollineni, merger of KIMS Hospitals Private Limited, and new operations management deal at Westfort Hospital, Thrissur
Krishna Institute of Medical Sciences Limited approved reappointments of key executives including CEO Dr. Abhinay Bollineni and Chairman & Managing Director Dr. Bhaskara Rao Bollineni for five-year terms. The board also approved the merger of its wholly owned subsidiary KIMS Hospitals Private Limited and an operations agreement for Westfort Hospital, Thrissur, during its November 4, 2026 meeting.
Krishna Institute of Medical Sciences Limited
Corporate Action
Krishna Institute of Medical Sciences Limited announced significant leadership reappointments, approved its subsidiary's merger, and authorized a new operations agreement for a hospital in Thrissur at its board meeting held on November 4, 2026.
The company approved unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026, along with limited review reports from statutory auditors.
The board sanctioned the merger of its wholly owned subsidiary, KIMS Hospitals Private Limited, with the parent company, Krishna Institute of Medical Sciences Limited.
An operations and management agreement was approved between KIMS Swastha Private Limited (a wholly owned subsidiary) and LOVR Institute of Medical Sciences Limited for Westfort Hospital located in Thrissur.
In leadership updates, Dr. Abhinay Bollineni was reappointed as Director and CEO for a further term of five years.
Dr. Bhaskara Rao Bollineni was reappointed as Chairman and Managing Director for five years, including continuation beyond the age of 70 years, as approved by the nomination and remuneration committee and the board of directors, respectively, with terms effective from the meeting date onwards, pending shareholder approval through a postal ballot notice planned for reappointments of key directors including Ms. Dandamudi Anitha as Whole-time Director.
Highlights
- Approval of unaudited standalone and consolidated financial results for Q2 and H1 ending September 30, 2026.
- Merger approved for KIMS Hospitals Private Limited with Krishna Institute of Medical Sciences Limited.
- Operations and Management Agreement approved for Westfort Hospital, Thrissur, via KIMS Swastha Private Limited and LOVR Institute of Medical Sciences Limited.
- Dr. Abhinay Bollineni reappointed as Director and CEO for five years.
- Dr. Bhaskara Rao Bollineni reappointed as Chairman and Managing Director for five years with continuation beyond 70 years of age.
- Reappointment of Ms. Dandamudi Anitha as Whole-time Director approved for five years.
Key Data Snapshot
What happened
- Krishna Institute of Medical Sciences Limited held a board meeting on 4th November 2026 to approve key decisions.
- The board approved the unaudited Q2 and half-year financial results for the period ending 30th September 2026.
- A merger of wholly owned subsidiary KIMS Hospitals Private Limited into the parent company was sanctioned.
- An Operations and Management Agreement was finalized for Westfort Hospital in Thrissur.
- Leadership reappointments were approved, including the CEO, Chairman & Managing Director, and Whole-time Director for five-year terms.
Key details
- Dr. Abhinay Bollineni was reappointed as Director and CEO for another five years.
- Dr. Bhaskara Rao Bollineni was reappointed as Chairman and Managing Director for a five-year term, including continuation beyond age 70.
- Ms. Dandamudi Anitha was reappointed as Whole-time Director for five years.
- The merger involves combining KIMS Hospitals Private Limited operations with Krishna Institute of Medical Sciences Limited.
- The operations and management agreement involves KIMS Swastha Private Limited and LOVR Institute of Medical Sciences Limited for Westfort Hospital, Thrissur.
- Postal ballot notice will be issued for the reappointments as per regulatory requirements.
Regulatory and governance context
- Financial results and disclosures are available on the company website and stock exchanges as per SEBI Listing Obligations and Disclosure Requirements Regulations 2015.
- The reappointments and merger approvals follow recommendations from the Nomination and Remuneration Committee.
- The board meeting was conducted in compliance with SEBI regulations and concluded within four hours on the date specified.
Highlights
- Approval of unaudited standalone and consolidated financial results for Q2 and H1 ending September 30, 2026.
- Merger approved for KIMS Hospitals Private Limited with Krishna Institute of Medical Sciences Limited.
- Operations and Management Agreement approved for Westfort Hospital, Thrissur, via KIMS Swastha Private Limited and LOVR Institute of Medical Sciences Limited.
- Dr. Abhinay Bollineni reappointed as Director and CEO for five years.
- Dr. Bhaskara Rao Bollineni reappointed as Chairman and Managing Director for five years with continuation beyond 70 years of age.
- Reappointment of Ms. Dandamudi Anitha as Whole-time Director approved for five years.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Corporate Action
View allLatest corporate announcements and market updates in Corporate Action.
Tube Investments of India Announces Q2 2026-27 Financial Results and Rs. 83 Crore Capacity Expansion Plan
Tube Investments of India Limited reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, posting a profit after tax of Rs. 188.16 crore for the quarter. Alongside, the company approved a Rs. 83 crore capital expenditure to enhance capacity at its Cold Rolled Steel Strips manufacturing facility in Avadi, aiming to meet increased demand by fiscal 2027-28.
Read Full Story
LG Electronics India expands into Vehicle Solutions Business and approves Q2/FH 2026 unaudited financial results
LG Electronics India Limited has approved entering the Vehicle Solutions Business, which covers automotive electronics manufacturing and services, alongside approving its unaudited financial results for the quarter and half year ended September 30, 2026.
Read Full Story
Mahindra & Mahindra Posts Rs. 11,164 Crore Profit After Tax in H1 2026 with Rs. 1.18 Lakh Crore Total Income
Mahindra & Mahindra Limited reported a consolidated profit after tax of Rs. 11,164.33 crore for the half year ended September 30, 2026, supported by total income of Rs. 1,17,943.75 crore across all segments, led by the Automotive business.
Read Full Story
